Literature DB >> 32960352

Imaging of facial neuritis using T2-weighted gradient-echo fast imaging employing steady-state acquisition after gadolinium injection.

Magali Hector1, Ahmad Alnadji2, Francis Veillon2, Maher Abu Eid2, Anne Charpiot3, Christian Debry3, Aïna Venkatasamy2,4.   

Abstract

BACKGROUND: MRI is the modality of choice for the imaging of facial neuritis. Previously, gadolinium-enhanced T1-weighted imaging of the petrous bone, then FLAIR sequences were thought to be most informative for acute facial neuritis imaging. The aim of this study is to evaluate the value of contrast-enhanced T2-weighted sequence for the diagnosis of acute facial neuritis and compare it to contrast-enhanced T1-weighted and FLAIR sequences.
METHODS: We included 50 patients with an acute unilateral idiopathic peripheral facial neuritis. An MRI (3 T) with three sequences was performed (T1-weighted, T2-weighted and FLAIR), all acquired after intravenous contrast-media injection.
RESULTS: The contrast-enhanced T2-weighted sequence appeared to be the most accurate one for the diagnosis of acute facial neuritis (Se 94%, Sp 100%, accuracy 98.2%, p < 0.001), with a pathological facial nerve strongly (grade 2-3) enhancing and a homogenous enhancement along the course of the entire facial nerve. Contrast-enhanced T1-weighted (Se 80%, Sp 100%, accuracy 94.1%) and FLAIR sequences (92%, Sp 88%, accuracy 90%, p < 0.001) showed lower accuracy. On T1-weighted sequence, a strong enhancement (blurred margins) of the canalicular segment was observed in 80% of the cases when it was never observed in normal nerves.
CONCLUSION: A strong (= iso to hyperintense to the petrous fat signal) and diffuse (all segments) enhancement of the facial nerve on T2-weighted steady-state free precession sequence is a sensitive and specific sign for the diagnosis of acute idiopathic facial neuritis, and appears superior to T1WI and FLAIR sequences.

Entities:  

Keywords:  Contrast-enhanced T1-weighted sequence; Contrast-enhanced T2-weighted sequence; FLAIR sequence; Facial neuritis; MRI

Year:  2020        PMID: 32960352     DOI: 10.1007/s00405-020-06375-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  7 in total

1.  MR diagnosis of facial neuritis: diagnostic performance of contrast-enhanced 3D-FLAIR technique compared with contrast-enhanced 3D-T1-fast-field echo with fat suppression.

Authors:  H K Lim; J H Lee; D Hyun; J W Park; J L Kim; H y Lee; S Park; J H Ahn; J H Baek; C G Choi
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-29       Impact factor: 3.825

2.  The clinical significance of findings obtained on 3D-FLAIR MR imaging in patients with Ramsay-Hunt syndrome.

Authors:  Mi S Chung; Jeong H Lee; Dae Y Kim; Young-Min Lim; Joong H Ahn; Yu S Sung; Young J Choi; Ra G Yoon; Jung H Baek
Journal:  Laryngoscope       Date:  2014-10-27       Impact factor: 3.325

3.  Facial nerve enhancement in MR imaging.

Authors:  D L Daniels; L F Czervionke; K W Pojunas; G A Meyer; S J Millen; A L Williams; V M Haughton
Journal:  AJNR Am J Neuroradiol       Date:  1987 Jul-Aug       Impact factor: 3.825

4.  T2-weighted three-dimensional fast spin-echo MR in inflammatory peripheral facial nerve palsy.

Authors:  S Sartoretti-Schefer; S Kollias; W Wichmann; A Valavanis
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

5.  MRI exploration of the intrapetrous facial nerve.

Authors:  N Girard; M Poncet; A Chays; A Florence; D Gignac; J Magnan; C Raybaud
Journal:  J Neuroradiol       Date:  1993-12       Impact factor: 3.447

6.  Idiopathic, herpetic, and HIV-associated facial nerve palsies: abnormal MR enhancement patterns.

Authors:  S Sartoretti-Schefer; W Wichmann; A Valavanis
Journal:  AJNR Am J Neuroradiol       Date:  1994-03       Impact factor: 3.825

7.  3D-FLAIR MRI in facial nerve paralysis with and without audio-vestibular disorder.

Authors:  Seiichi Nakata; Terukazu Mizuno; Shinji Naganawa; Makoto Sugiura; Tadao Yoshida; Masaaki Teranishi; Michihiko Sone; Tsutomu Nakashima
Journal:  Acta Otolaryngol       Date:  2010-05       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.